IRIS Accounts Production v23.3.0.418 10063513 director 1.4.22 31.3.23 31.3.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh100635132022-03-31100635132023-03-31100635132022-04-012023-03-31100635132021-03-31100635132021-04-012022-03-31100635132022-03-3110063513ns10:Originalns15:EnglandWales2022-04-012023-03-3110063513ns14:PoundSterlingns10:Original2022-04-012023-03-3110063513ns10:Originalns10:Director12022-04-012023-03-3110063513ns10:Original2022-04-012023-03-3110063513ns10:Original2023-03-3110063513ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3110063513ns10:Originalns10:SmallEntities2022-04-012023-03-3110063513ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3110063513ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3110063513ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3110063513ns10:Originalns10:FullAccounts2022-04-012023-03-3110063513ns10:Originalns10:RegisteredOffice2022-04-012023-03-3110063513ns10:Original2022-03-3110063513ns10:Originalns5:CurrentFinancialInstruments2023-03-3110063513ns10:Originalns5:CurrentFinancialInstruments2022-03-3110063513ns5:ShareCapitalns10:Original2023-03-3110063513ns5:ShareCapitalns10:Original2022-03-3110063513ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3110063513ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3110063513ns10:Originalns5:PlantMachinery2022-04-012023-03-3110063513ns10:Originalns5:ComputerEquipment2022-04-012023-03-3110063513ns10:Original2021-04-012022-03-3110063513ns10:Originalns5:PlantMachinery2022-03-3110063513ns10:Originalns5:ComputerEquipment2022-03-3110063513ns10:Original2022-03-3110063513ns10:Originalns5:PlantMachinery2023-03-3110063513ns10:Originalns5:ComputerEquipment2023-03-3110063513ns10:Originalns5:PlantMachinery2022-03-3110063513ns10:Originalns5:ComputerEquipment2022-03-3110063513ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3110063513ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3110063513ns10:Originalns5:WithinOneYear2023-03-3110063513ns10:Originalns5:WithinOneYear2022-03-3110063513ns5:BetweenOneFiveYearsns10:Original2023-03-3110063513ns5:BetweenOneFiveYearsns10:Original2022-03-3110063513ns10:Originalns5:AllPeriods2023-03-3110063513ns10:Originalns5:AllPeriods2022-03-31
REGISTERED NUMBER: 10063513 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2023

for

My Breast My Health Limited

My Breast My Health Limited (Registered number: 10063513)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


My Breast My Health Limited

Company Information
for the Year Ended 31 March 2023







DIRECTOR: Miss T Gandamihardja





REGISTERED OFFICE: 86-90 Paul Street
London
EC2A 4NE





REGISTERED NUMBER: 10063513 (England and Wales)





ACCOUNTANTS: Thompsons Accountancy Services Limited
Chartered Accountants
Grove House
1 Grove Place
Bedford
Bedfordshire
MK40 3JJ

My Breast My Health Limited (Registered number: 10063513)

Statement of Financial Position
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 3,024 2,297

CURRENT ASSETS
Debtors 6 21,121 49,943
Cash at bank 163,372 117,789
184,493 167,732
CREDITORS
Amounts falling due within one year 7 29,529 25,688
NET CURRENT ASSETS 154,964 142,044
TOTAL ASSETS LESS CURRENT
LIABILITIES

157,988

144,341

PROVISIONS FOR LIABILITIES 575 436
NET ASSETS 157,413 143,905

CAPITAL AND RESERVES
Allotted, called up and
fully paid share capital 200 200
Retained earnings 157,213 143,705
157,413 143,905

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

My Breast My Health Limited (Registered number: 10063513)

Statement of Financial Position - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 October 2023 and were signed by:





Miss T Gandamihardja - Director


My Breast My Health Limited (Registered number: 10063513)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

My Breast My Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 33% on cost
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

My Breast My Health Limited (Registered number: 10063513)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

3. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

5. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 April 2022 - 5,155 5,155
Additions 1,709 769 2,478
At 31 March 2023 1,709 5,924 7,633
DEPRECIATION
At 1 April 2022 - 2,858 2,858
Charge for year 380 1,371 1,751
At 31 March 2023 380 4,229 4,609
NET BOOK VALUE
At 31 March 2023 1,329 1,695 3,024
At 31 March 2022 - 2,297 2,297

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade debtors 8,572 5,096
Other debtors 12,549 40,549
Prepayments - 4,298
21,121 49,943

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Tax 14,171 13,925
Social security and other taxes 134 -
Directors' current accounts 12,929 9,348
Accrued expenses 2,295 2,415
29,529 25,688

My Breast My Health Limited (Registered number: 10063513)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
31.3.23 31.3.22
£    £   
Within one year 12,425 -
Between one and five years 13,460 -
25,885 -